scispace - formally typeset
Search or ask a question
Author

Thomas A. Golper

Bio: Thomas A. Golper is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Peritoneal dialysis & Hemodialysis. The author has an hindex of 50, co-authored 185 publications receiving 12179 citations. Previous affiliations of Thomas A. Golper include University of Arkansas for Medical Sciences & University of Oregon.


Papers
More filters
Journal Articleβ€’

2,609Β citations

Journal Articleβ€’
Andrew S. Levey1, Michael V. Rocco2, Sharon Anderson3, Sharon P. Andreoli4, George R. Bailie5, George L. Bakris6, Mary Beth Callahan, Jane H. Greene7, Cynda Ann Johnson8, James P. Lash9, Peter A. McCullough10, Edgar R. Miller11, Joseph V. Nally12, John D. Pirsch13, Ronald J. Portman14, Mary Ann Sevick15, Domenic A. Sica16, Donald E. Wesson17, Lawrence Y. Agodoa18, Kline Bolton19, Jeffrey A. Cutler18, Tom Hostetter18, Joseph Lau1, Katrin Uhlig1, Priscilla Chew1, Annamaria T. Kausz1, Bruce Kupelnick1, Gowri Raman1, Mark J. Sarnak1, Chenchen Wang1, Brad C. Astor11, Garabed Eknoyan, Adeera Levin, Nathan W. Levin, George R. Bailie5, Bryan N. Becker, Gavin J. Becker, Jerrilynn D. Burrowes, Fernando Carrera, David N. Churchill, Allan J. Collins, Peter W. Crooks, Dick DeZeeuw, Thomas A. Golper, Frank A. Gotch, Antonio M. Gotto, Roger Greenwood, Joel W. Greer, Richard H. Grimm, William E. Haley, Ronald J. Hogg, Alan R. Hull, Lawrence G. Hunsicker, Michael J. Klag, Saulo Klahr, Norbert Lameire, Francesco Locatelli, Sally McCulloch, Maureen Michael, John M. Newmann, Allen R. Nissenson, Keith C. Norris, Gregorio T. Obrador, William F. Owen, Thakor G. Patel, Glenda Payne, Claudio Ronco, Rosa A. Rivera-Mizzoni, Anton C. Schoolwerth, Robert A. Star, Michael W. Steffes, Theodore I. Steinman, John Pierre Wauters, Nanette K. Wenger, Josephine P. Briggs, Sally Burrows-Hudson, Derrick Latos, Donna Mapes, Edith Oberley, Brian J.G. Pereira, Kerry Willis, Anthony Gucciardo, Donna Fingerhut, Margaret Klette, Elicia SchachneΒ β€’
TL;DR: The purpose of the Executive Summary is to provide a "stand-alone" summary of the background, scope, methods, and key recommendations, as well as the complete text of the guideline statements.

1,145Β citations

Bookβ€’
01 Jan 1999
TL;DR: The data base for rational guidelines to safe, efficacious drug prescribing in adults with renal insufficiency is presented in tabular form in this paper, where recommendations are based on pharmacokinetic variables in normal subjects.
Abstract: The data base for rational guidelines to safe, efficacious drug prescribing in adults with renal insufficiency are presented in tabular form. Current medical literature was extensively surveyed to provide as much specific information as possible. When information is lacking, however, recommendations are based on pharmacokinetic variables in normal subjects. Nephrotoxicity, important adverse effects, and special considerations in renal patients are noted. Adjustments are suggested for hemodialysis and peritoneal dialysis when appropriate.

486Β citations

Journal Articleβ€’DOIβ€’
TL;DR: The strikingly elevated mortality risk with lowpredialysis systolic BP suggests that low predialysis BP needs to be viewed with great concern and avoided where possible, and greater attention to postdialysis hypertension is suggested.

439Β citations

Journal Articleβ€’DOIβ€’
TL;DR: Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota; Albany College of Pharmacy, Albany, New York; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Renal Division.
Abstract: Department of Medicine,1 Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, Minnesota; Albany College of Pharmacy,2 Albany, New York, U.S.A.; Department of Peritoneal Dialysis,3 Academic Medical Center, Amsterdam, The Netherlands; Manchester Royal Infirmary,4 Manchester, United Kingdom; Vanderbilt University Medical Center,5 Nashville, Tennessee; Baxter Healthcare Corporation,6 McGaw Park, Illinois, U.S.A.; Renal Division,7 Jikei-kai University, School of Medicine, Tokyo, Japan; University of Pittsburgh Medical Center,8 Pittsburgh, Pennsylvania, U.S.A.; Renal Division,9 Department of Medicine, Evangelic School of Medicine, Curitiba Parana, Brazil; University of Toronto,10 Toronto Hospital, Toronto, Ontario, Canada

424Β citations


Cited by
More filters
Journal Articleβ€’DOIβ€’
TL;DR: The CKD-EPI creatinine equation is more accurate than the Modification of Diet in Renal Disease Study equation and could replace it for routine clinical use.
Abstract: The Modification of Diet in Renal Disease (MDRD) Study equation underestimates glomerular filtration rate (GFR) in patients with mild kidney disease. Levey and associates therefore developed and va...

18,691Β citations

Journal Articleβ€’DOIβ€’
TL;DR: The role of vitamin D in skeletal and nonskeletal health is considered and strategies for the prevention and treatment ofitamin D deficiency are suggested.
Abstract: Once foods in the United States were fortified with vitamin D, rickets appeared to have been conquered, and many considered major health problems from vitamin D deficiency resolved. But vitamin D deficiency is common. This review considers the role of vitamin D in skeletal and nonskeletal health and suggests strategies for the prevention and treatment of vitamin D deficiency.

11,849Β citations

Journal Articleβ€’DOIβ€’
Arif Khwaja1β€’
TL;DR: The guidelines focused on 4 key domains: (1) AKI definition, (2) prevention and treatment of AKI, (3) contrastinduced AKI (CI-AKI) and (4) dialysis interventions for the treatment ofAKI.
Abstract: tion’, implying that most patients β€˜should’ receive a particular action. In contrast, level 2 guidelines are essentially β€˜suggestions’ and are deemed to be β€˜weak’ or discretionary, recognising that management decisions may vary in different clinical contexts. Each recommendation was further graded from A to D by the quality of evidence underpinning them, with grade A referring to a high quality of evidence whilst grade D recognised a β€˜very low’ evidence base. The overall strength and quality of the supporting evidence is summarised in table 1 . The guidelines focused on 4 key domains: (1) AKI definition, (2) prevention and treatment of AKI, (3) contrastinduced AKI (CI-AKI) and (4) dialysis interventions for the treatment of AKI. The full summary of clinical practice statements is available at www.kdigo.org, but a few key recommendation statements will be highlighted here.

6,247Β citations

01 Feb 2009
TL;DR: This Secret History documentary follows experts as they pick through the evidence and reveal why the plague killed on such a scale, and what might be coming next.
Abstract: Secret History: Return of the Black Death Channel 4, 7-8pm In 1348 the Black Death swept through London, killing people within days of the appearance of their first symptoms. Exactly how many died, and why, has long been a mystery. This Secret History documentary follows experts as they pick through the evidence and reveal why the plague killed on such a scale. And they ask, what might be coming next?

5,234Β citations

Journal Articleβ€’DOIβ€’
TL;DR: The goal is to disseminate the simple definition and five-stage classification system of Chronic kidney disease, to summarize the major recommendations on early detection of chronic kidney disease in adults, and to consider some of the issues associated with these recommendations.
Abstract: Chronic kidney disease is a worldwide public health problem with an increasing incidence and prevalence, poor outcomes, and high cost. Outcomes of chronic kidney disease include not only kidney failure but also complications of decreased kidney function and cardiovascular disease. Current evidence suggests that some of these adverse outcomes can be prevented or delayed by early detection and treatment. Unfortunately, chronic kidney disease is underdiagnosed and undertreated, in part as a result of lack of agreement on a definition and classification of its stages of progression. Recent clinical practice guidelines by the National Kidney Foundation 1) define chronic kidney disease and classify its stages, regardless of underlying cause, 2) evaluate laboratory measurements for the clinical assessment of kidney disease, 3) associate the level of kidney function with complications of chronic kidney disease, and 4) stratify the risk for loss of kidney function and development of cardiovascular disease. The guidelines were developed by using an approach based on the procedure outlined by the Agency for Healthcare Research and Quality. This paper presents the definition and five-stage classification system of chronic kidney disease and summarizes the major recommendations on early detection in adults. Recommendations include identifying persons at increased risk (those with diabetes, those with hypertension, those with a family history of chronic kidney disease, those older than 60 years of age, or those with U.S. racial or ethnic minority status), detecting kidney damage by measuring the albumin-creatinine ratio in untimed ("spot") urine specimens, and estimating the glomerular filtration rate from serum creatinine measurements by using prediction equations. Because of the high prevalence of early stages of chronic kidney disease in the general population (approximately 11% of adults), this information is particularly important for general internists and specialists.

4,363Β citations